Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

March 2016 Issue of The Ophthalmologist

In the March issue, Upfront’s topics range from the two-year Protocol T results, to a potentially electrifying adult amblyopia treatment. The cover feature tells the story of NGF: the polymath molecule, which has potential applications from cornea to retina. In Practice sees Mitch Jackson and David Chang debate FLACS, and in NextGen we benchmark corneal OCT. Profession sees Hakam Ghabra discuss turning “What If?” to “Why Not?” – to an IOL prototype, and we Sit Down With Anat Loewenstein, Chair of Ophthalmology, Tel Aviv Medical Centre, Israel.

Register to download

Register here to download any issue of The Ophthalmologist for FREE.


Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Business & Profession Professional Development

The Impact of The List

The Power List is a celebration of excellence – and the impact it’s had on those it highlights has been impressive

Business & Profession Other

Nominations are now closed!

Nominations for The Ophthalmologist 2016 Power List are now closed.

Subspecialties Basic & Translational Research

Protocol T: Two Years On

| Mark Hillen

Benefits achieved in the first year maintained; VA performance gap in patients with low baseline vision narrows

Subspecialties Basic & Translational Research

Beyond the “Critical Period”

Could transcranial direct current stimulation treat amblyopia in adults?

Business & Profession Health Economics and Policy

Spending and Trending shows some interesting trends in ophthalmic therapy prescription and spend over the last five years

Subspecialties Basic & Translational Research

Common Keratoconus Causes Uncovered

Racial background modifies risk; diabetes protects, but asthma and sleep apnea predisposes

Business & Profession Health Economics and Policy

The App That Cuts Clinic Queues

Could patient self-testing help to free up eye clinics, and spot macular degeneration earlier than traditional testing methods?

Business & Profession Health Economics and Policy

Five Years in A&E

Many patients visit the emergency room with ocular problems that might be better treated elsewhere – why? And what’s the solution?

Subspecialties Basic & Translational Research

The Polymath Molecule

From cornea to retina, NGF’s regenerative and neuroprotective potential seems immense. What does the future hold for this versatile little neurotrophin?

Subspecialties Cataract

The US View on EUREQUO

Last month, Peter Barry reviewed the EUREQUO registry. This month, we get the transatlantic perspective

Subspecialties Imaging & Diagnostics

Benchmarking Corneal OCT

What does analysis of the last five years of literature on corneal optical coherence tomography tell us about the priorities of the field, and the contributors to it?

Business & Profession Professional Development

From “What If?” to “Why Not?”

| Hakam Ghabra

Taking an ophthalmic startup from concept to reality

Business & Profession Cataract

Do Ophthalmologists Undergo LASIK?

| Gregory D. Parkhurst

Refractive surgeons know the pros and cons of LASIK better than anyone – but how many would recommend it to their family, or undergo it themselves?

Subspecialties Professional Development

Following Destiny’s Path

Sitting Down With... Anat Loewenstein, Chair of the Department of Ophthalmology, Tel Aviv Medical Centre, Professor of Ophthalmology and Vice Dean, Tel Aviv University, Israel.

Other issues of 2016